Logo

Karen Chapman

Mar 06, 2017
Oncocyte has announced the resignation of its vice president of research, Karen Chapman in a filing with the US Securities and Exchange Commission. The firm said Chapman's employment will terminate on March 22. Under an employment termination and release agreement, Oncocyte said it has agreed to extend the expiration date of Chapman's employee stock options to February 28, 2018, with the agreement that she not offer, sell, or otherwise dispose of any "Lock-up Shares," before May 31, 2017 without the company's consent.
Breaking News
The Scan

ChatGPT Does As Well As Humans Answering Genetics Questions, Study Finds

Researchers in the European Journal of Human Genetics had ChatGPT answer genetics-related questions, finding it was about 68 percent accurate, but sometimes gave different answers to the same question.

Sequencing Analysis Examines Gene Regulatory Networks of Honeybee Soldier, Forager Brains

Researchers in Nature Ecology & Evolution find gene regulatory network differences between soldiers and foragers, suggesting bees can take on either role.

Analysis of Ashkenazi Jewish Cohort Uncovers New Genetic Loci Linked to Alzheimer's Disease

The study in Alzheimer's & Dementia highlighted known genes, but also novel ones with biological ties to Alzheimer's disease.

Tara Pacific Expedition Project Team Finds High Diversity Within Coral Reef Microbiome

In papers appearing in Nature Communications and elsewhere, the team reports on findings from the two-year excursion examining coral reefs.